Institution · Heidelberg University
Most cited papers from Heidelberg University
Heidelberg University
What are the most cited papers from Heidelberg University?
The most cited paper from Heidelberg University is "Comprehensive molecular profiling of lung adenocarcinoma" (Eric A. Collisson et al., 2014), with 5,968 citations. Next come "Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study" (3,188) and "Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials" (2,568).
Showing 50 of 59 papers. Every paper with more than 594 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Comprehensive molecular profiling of lung adenocarcinoma Eric A. Collisson et al. · Nature | 8 Jul 2014 | 5,968 |
| 2 | Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study Jaimie D Steinmetz et al. · The Lancet Global Health | Dec 2020 | 3,188 |
| 3 | Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials Werner Hacke et al. · The Lancet | Mar 2004 | 2,568 |
| 4 | Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma Samuel A. Wells, Sylvia L. Asa, Henning Dralle et al. · Thyroid | 27 Mar 2015 | 2,457 |
| 5 | European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013 Michele Baccarani et al. · Blood | 27 Jun 2013 | 2,005 |
| 6 | Quantitative Expression of Toll-Like Receptor 1–10 mRNA in Cellular Subsets of Human Peripheral Blood Mononuclear Cells and Sensitivity to CpG Oligodeoxynucleotides Veit Hornung, Simon Rothenfußer, Stefanie Britsch et al. · The Journal of Immunology | May 2002 | 1,948 |
| 7 | The hallmarks of cancer Tony Gutschner, Sven Diederichs · RNA Biology | Jun 2012 | 1,862 |
| 8 | Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer Emmet O’Brien, Nely Wigler, Moshe Inbar et al. · Annals of Oncology | Mar 2004 | 1,747 |
| 9 | Record-setting algal bloom in Lake Erie caused by agricultural and meteorological trends consistent with expected future conditions Anna M. Michalak et al. · Proceedings of the National Academy of Sciences | Apr 2013 | 1,479 |
| 10 | Idarucizumab for Dabigatran Reversal Charles V. Pollack, Paul A. Reilly, John W. Eikelboom et al. · New England Journal of Medicine | 22 Jun 2015 | 1,471 |
| 11 | Understanding RAGE, the receptor for advanced glycation end products Angelika Bierhaus, Per M. Humpert, Michael Morcos et al. · Journal of Molecular Medicine | 23 Aug 2005 | 1,300 |
| 12 | Therapeutic developments in pancreatic cancer: current and future perspectives John P. Neoptolemos, Jorg H. Kleeff, Patrick Michl et al. · Nature Reviews Gastroenterology & Hepatology | May 2018 | 1,262 |
| 13 | European Stroke Organization Guidelines for the Management of Intracranial Aneurysms and Subarachnoid Haemorrhage Thorsten Steiner, Seppo Juvela, Andreas Wilhelm Unterberg et al. · Cerebrovascular Diseases | 2013 | 1,152 |
| 14 | European Society of Cardiology: cardiovascular disease statistics 2021 Adam Timmis et al. · European Heart Journal | 20 Dec 2021 | 1,141 |
| 15 | Introduction to the Theory of Neural Computation John Hertz, Anders Krogh, Richard G. Palmer et al. · Physics Today | Dec 1991 | 1,074 |
| 16 | Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2–Positive and Triple-Negative Primary Breast Cancers Carsten Denkert et al. · Journal of Clinical Oncology | 23 Dec 2014 | 1,047 |
| 17 | Pallidal Deep-Brain Stimulation in Primary Generalized or Segmental Dystonia Andreas R. Kupsch et al. · New England Journal of Medicine | 8 Nov 2006 | 1,032 |
| 18 | WAHRHEIT UND METHODE Hans‐Georg Gadamer · Bijdragen | 1973 | 1,027 |
| 19 | Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma Thierry T.F. Facon et al. · New England Journal of Medicine | 29 May 2019 | 1,022 |
| 20 | Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke Gregory J. del Zoppo, Klaus Poeck, Michael S. Pessin et al. · Annals of Neurology | Jul 1992 | 1,004 |
| 21 | Metal-Protein Attenuation With Iodochlorhydroxyquin (Clioquinol) Targeting Aβ Amyloid Deposition and Toxicity in Alzheimer Disease Craig Ritchie, Ashley Ian Bush, Andrew James Mackinnon et al. · Archives of Neurology | Dec 2003 | 990 |
| 22 | One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor Heikki Joensuu et al. · JAMA | 27 Mar 2012 | 982 |
| 23 | Atmospheric composition change – global and regional air quality P. S. Monks et al. · Atmospheric Environment | 29 Aug 2009 | 974 |
| 24 | Lutropin-Choriogonadotropin Receptor: An Unusual Member of the G Protein-Coupled Receptor Family Keith McFarland, Rolf Sprengel, HEIDI S. PHILLIPS et al. · Science | 4 Aug 1989 | 949 |
| 25 | Histopathological Findings in Brain Tissue Obtained during Epilepsy Surgery Ingmar Blümcke et al. · New England Journal of Medicine | 25 Oct 2017 | 947 |
| 26 | Probabilistic Forecasting Tilmann Gneiting, Matthias Katzfuß · Annual Review of Statistics and Its Application | 3 Jan 2014 | 923 |
| 27 | Advanced Heart Failure: A Position Statement of the Heart Failure Association of the European Society of Cardiology María G. Crespo‐Leiro et al. · European Journal of Heart Failure | 28 May 2018 | 889 |
| 28 | COVID-19 control in China during mass population movements at New Year Simiao Chen, Juntao Yang, Weizhong Yang et al. · The Lancet | 24 Feb 2020 | 885 |
| 29 | Ecological risk assessment of atrazine in North American surface waters Keith R. Solomon, John Paul Giesy, Thomas W. LaPoint et al. · Environmental Toxicology and Chemistry | 13 Nov 2012 | 864 |
| 30 | HIV-1 Assembly, Budding, and Maturation Wesley I. Sundquist, Hans‐Georg Kräusslich · Cold Spring Harbor Perspectives in Medicine | 13 Mar 2012 | 835 |
| 31 | RNA methylation by Dnmt2 protects transfer RNAs against stress-induced cleavage Matthias Schaefer, Tim Pollex, Katharina Hanna et al. · Genes & Development | Aug 2010 | 798 |
| 32 | Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series Stefan Kommoss et al. · Annals of Oncology | 7 Feb 2018 | 794 |
| 33 | Coefficients for calculating thermodynamic and transport properties of individual species Bonnie J. McBride, Sanford Gordon, Martin A. Reno · NASA STI Repository (National Aeronautics and Space Administration) | Oct 1993 | 787 |
| 34 | Protection From Colorectal Cancer After Colonoscopy Hermann Brenner, Jenny C. Chang-Claude, Christoph M. Seiler et al. · Annals of Internal Medicine | 4 Jan 2011 | 776 |
| 35 | The nuclear pore complex: understanding its function through structural insight Martin Beck, Ed Hurt · Nature Reviews Molecular Cell Biology | 21 Dec 2016 | 771 |
| 36 | Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. Martina Müller, Susanne J. M. Strand, Hubert Hug et al. · Journal of Clinical Investigation | Feb 1997 | 771 |
| 37 | Sarcopenia: A Time for Action. An SCWD Position Paper Jürgen Martin Bauer et al. · Journal of Cachexia Sarcopenia and Muscle | 15 Sep 2019 | 745 |
| 38 | cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties. Allan W. Bach, N C Lan, Dana L. Johnson et al. · Proceedings of the National Academy of Sciences | Jul 1988 | 729 |
| 39 | Early Hemicraniectomy in Patients With Complete Middle Cerebral Artery Infarction Stefan Schwab, Thorsten Steiner, A. Aschoff et al. · Stroke | Sep 1998 | 718 |
| 40 | Effect size guidelines for cross-lagged effects. Ulrich R. Orth, Laurenz Linus Meier, Janina Larissa Bühler et al. · Psychological Methods | 23 Jun 2022 | 717 |
| 41 | Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides Tobias Hartmann, Sophie C. Bieger, Babara Brühl et al. · Nature Medicine | Sep 1997 | 715 |
| 42 | The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis Armin L. Schneider, Carola Krüger, Tobias Steigleder et al. · Journal of Clinical Investigation | 8 Jul 2005 | 701 |
| 43 | Fibroblast Growth Factor 23 (FGF23) Predicts Progression of Chronic Kidney Disease Danilo Fliser, Barbara Kollerits, Ulrich Neyer et al. · Journal of the American Society of Nephrology | 26 Jul 2007 | 698 |
| 44 | Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple Myeloma Ajai Chari et al. · New England Journal of Medicine | 21 Aug 2019 | 689 |
| 45 | The Amyloid Precursor Protein of Alzheimer's Disease in the Reduction of Copper(II) to Copper(I) Gerd Multhaup, Andrea Schlicksupp, Lars Hesse et al. · Science | 8 Mar 1996 | 680 |
| 46 | The re-eutrophication of Lake Erie: Harmful algal blooms and hypoxia Susan B. Watson, Carol J. Miller, George B. Arhonditsis et al. · Harmful Algae | 18 May 2016 | 660 |
| 47 | Allogeneic hematopoietic cell transplantation for metastatic breast cancer Naoto Tada Ueno, J. Douglas Rizzo, Taner Demirer et al. · Bone Marrow Transplantation | 17 Dec 2007 | 658 |
| 48 | CT-Definable Subtypes of Chronic Obstructive Pulmonary Disease: A Statement of the Fleischner Society David A. Lynch, John H. M. Austin, James C. Hogg et al. · Radiology | 11 May 2015 | 657 |
| 49 | Most Pancreatic Cancer Resections are R1 Resections Iréne Esposito, Jorg H. Kleeff, Frank Bergmann et al. · Annals of Surgical Oncology | 19 Mar 2008 | 656 |
| 50 | Immunocytochemical demonstration of vimentin in astrocytes and ependymal cells of developing and adult mouse nervous system J. Schnitzer, Werner Wilhelm Franke, Melitta Schachner · The Journal of Cell Biology | Aug 1981 | 642 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.